丙种球蛋白治疗婴幼儿重症肺炎疗效分析  

Analysis of the Efficacy of Gamma Globulin in the Treatment of Infants With Severe Pneumonia

作　　者：张均[1] ZHANG Jun(Department of Pediatrics,Macheng People's Hospital,Huanggang Hubei 438300,China)

机构地区：[1]麻城市人民医院儿科,湖北黄冈438300

出　　处：《中国卫生标准管理》2020年第9期63-65,共3页China Health Standard Management

摘　　要：目的分析丙种球蛋白治疗婴幼儿重症肺炎的有效性。方法随机将本院2018年1月-2019年8月收治的重症肺炎婴幼儿患儿55例分成两组,针对常规组27例实施常规的对症支持,针对观察组28例加用丙种球蛋白进行治疗,对比两组的治疗效果。结果观察组患儿治疗后的症状改善时间、住院时间、治疗优良率明显优于常规组患儿,差异有统计学意义(P <0.05);但两组婴幼儿重症肺炎患儿治疗后的不良反应发生率差异无统计学意义(P> 0.05)。结论针对重症肺炎的婴幼儿实施丙种球蛋白治疗能显著改善患儿高热、肺部啰音等症状,缩短患儿的住院时间,促进患儿康复及预后,安全性较高。Objective To analyze the effectiveness of gamma globulin in treating infants with severe pneumonia. Methods Fifty-five infants with severe pneumonia treated in the hospital from January 2018 to August 2019 were randomly divided into two groups, 27 patients in the conventional group were given routine symptomatic support, and 28 patients in the observation group were treated with gamma globulin, compare the treatment effect between the two groups. Results The symptoms improvement time, treatment time, and excellent treatment rate in the observation group were significantly better than those in the conventional group, the difference was statistically significant(P < 0.05);however, adverse reactions rate occurred after treatment in the two groups of children with severe pneumonia was not statistically significant different(P > 0.05). Conclusion The treatment of gamma globulin for infants with severe pneumonia can significantly improve symptoms such as high fever and lung snoring, shorten the treatment time of the child, promote recovery and prognosis of the child, and have higher safety.

关 键 词：丙种球蛋白 婴幼儿 重症 肺炎 治疗疗效 安全性 

分 类 号：R554[医药卫生—血液循环系统疾病]